Aurinia Pharmaceuticals I...

NASDAQ: AUPH · Real-Time Price · USD
12.27
0.18 (1.49%)
At close: Aug 15, 2025, 3:59 PM
12.44
1.43%
After-hours: Aug 15, 2025, 07:44 PM EDT

Aurinia Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
21.51M 23.34M 1.43M 14.35M 722K -10.75M -26.88M -13.45M -11.49M -26.21M -26.05M -8.99M -35.52M -37.63M -33.32M -50.26M -47.01M -50.38M
Depreciation & Amortization
2.3M 4.86M 4.86M -4.86M 4.84M 4.85M 4.95M 5.26M 719K 717K 219K 809K 840K 838K 688K 683K 702K 688K
Stock-Based Compensation
5.44M -3.41M 8.95M 8.33M 8.59M 5.74M 11.77M 11.81M 12.27M 9.47M 6.9M 8.32M 10.05M 7.02M 8.58M 7.09M 7.75M 7.82M
Other Working Capital
n/a -13.22M 22.95M 15.12M -5.36M 709K 10.82M -5.44M -1.38M 16.67M 4.47M 944K -5.92M 139K 4.12M -8.97M -4.19M 1.48M
Other Non-Cash Items
14.99M -1.93M -7.43M -5.73M 2.99M 19.23M 18.29M -675K -841K -2.39M -2.59M 540K 997K 1.51M -102K 13.91M -793K -2.11M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -12.9M -2.32M -5.6M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
n/a -24.97M 22.3M 4.94M 5.82M -10.76M 19.59M -13.9M 2.12M -13.25M 31.96M -16.04M -4.25M -18.49M -1.76M -11.68M 1.37M -9.56M
Operating Cash Flow
44.24M 1.3M 30.11M 17.03M 15.86M -18.6M 14.82M -13.28M -2.83M -31.67M 10.45M -15.36M -27.87M -46.75M -25.92M -40.25M -37.98M -53.54M
Capital Expenditures
-98K -17K -51.16K -129K -83.32K -12K -49.73K 105K -227K -509K 79K -37.68K -38.52K -79K -35K -63K -222K -1.18M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a 50K -167.26M n/a 37.68K 38.52K n/a n/a -159K n/a -1.04M
Purchase of Investments
-145.43M -91.99M -84.69M -145.27M -194.61M -121.26M -137.95M -122.77M -114.04M -142.4M -120.81M -170.23M -69.45M -163.5M -96.13M -125.84M -101.82M -115.17M
Sales Maturities Of Investments
132.25M 123.03M 123.97M -326.55M 156.04M 170.5M 131.65M 103M 120.53M 167.77M 118.21M 120.43M 115.11M 110.57M 90.67M 99.1M 103.71M 60.94M
Other Investing Acitivies
n/a n/a 226K 461.15M -43.69K 49.23M 157.25K -28K -11.91M 167.26M -495K -421K -39K -52.94M 17.67K -6.16M -183.87K -12.88M
Investing Cash Flow
-13.27M 31.03M 39.22M -10.57M -38.7M 49.23M -6.19M -19.7M -5.61M 24.86M -3.02M -50.22M 45.62M -53.02M -5.49M -32.81M 1.67M -67.25M
Debt Repayment
n/a -2.77M -3.03M -2.96M n/a n/a -6.54M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
-42.56M -46.92M -21.8M -130.46K -6.13M -12.3M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
1.6M n/a 1.79M 236K -2.14M -2.75M 966K -3.49M 1.14M 1.64M 688K n/a 1.34M 405K 8.98M 9.08M 1.28M 5.03M
Financial Cash Flow
-44.39M -49.34M -23.05M -2.72M -8.11M -15.05M -5.53M -2.33M 1.14M 1.64M 688K -23.87K 1.34M 405K 205.72M 9.08M 1.28M 5.03M
Net Cash Flow
-13.43M -17M 46.29M 3.73M -31.05M 15.58M 2.48M -35.31M -7.29M -5.17M 8.12M -65.58M 19.09M -99.36M 174.31M -63.97M -35.03M -115.76M
Free Cash Flow
44.14M 1.28M 30.06M 16.9M 15.78M -18.61M 14.77M -13.17M -3.05M -32.18M 10.53M -15.4M -27.91M -46.83M -25.96M -40.31M -38.2M -54.72M